Suvretta Capital Management, LLC Rocket Pharmaceuticals, Inc. Transaction History
Suvretta Capital Management, LLC
- $2.4 Billion
- Q4 2024
A detailed history of Suvretta Capital Management, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 2,566,951 shares of RCKT stock, worth $21 Million. This represents 1.34% of its overall portfolio holdings.
Number of Shares
2,566,951Holding current value
$21 Million% of portfolio
1.34%Shares
1 transactions
Others Institutions Holding RCKT
# of Institutions
243Shares Held
94.3MCall Options Held
262KPut Options Held
159K-
Rtw Investments, LP New York, NY17.7MShares$145 Million3.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.58MShares$53.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$50.6 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$42.5 Million1.26% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.71MShares$38.5 Million0.27% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $618M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...